Zentalis Pharmaceuticals (ZNTL) Interest Expenses (2019 - 2026)
Zentalis Pharmaceuticals (ZNTL) posted quarterly Interest Expenses of $51.7 million for Q1 2026, down 12.17% year-over-year from $58.9 million in Q1 2025, and up 469881.82% quarter-over-quarter from $11000.0 in Q4 2025.
Zentalis Pharmaceuticals (ZNTL) Interest Expenses (2019 - 2026) Analysis & Trends
Zentalis Pharmaceuticals' Interest Expenses history runs 8 years deep, the most recent figure standing at $51.7 million for Q1 2026.
- In Q1 2026, Interest Expenses fell 12.17% year-over-year to $51.7 million; the TTM figure through Mar 2026 stood at $51.7 million (down 12.17% YoY), while the FY2025 annual figure was $6.8 million, down 97.25% from the prior year.
- Interest Expenses for Q1 2026 stood at $51.7 million, up from $11000.0 in the prior quarter.
- The five-year high for Interest Expenses was $74.2 million in Q3 2022, with the low at $11000.0 in Q4 2025.
- The 5-year median for Interest Expenses is $38.2 million (2023), against an average of $37.2 million.
- The sharpest annual moves came in 2022 and 2025: Interest Expenses surged 8077.09% in 2022, then plunged 99.83% in 2025.
- Zentalis Pharmaceuticals' Interest Expenses stood at $74.2 million in 2022, then sank by 91.38% to $6.4 million in 2023, then climbed by 1.56% to $6.5 million in 2024, then slumped by 99.83% to $11000.0 in 2025, then surged by 469881.82% to $51.7 million in 2026.
- Business Quant data shows ZNTL's Interest Expenses at $51.7 million in Q1 2026, $11000.0 in Q4 2025, and $14.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Zentalis Pharmaceuticals | 255.14 Mn | 255.14 Mn | - | 49.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 49.88 Mn |
| Jun 30, 2026 | 49.88 Mn |
| Mar 31, 2026 | 51.70 Mn |
| Mar 31, 2026 | 51.70 Mn |
| Dec 31, 2025 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 14.83 Mn |
| Sep 30, 2025 | 14.83 Mn |
| Jun 30, 2025 | 57.08 Mn |
| Jun 30, 2025 | 57.08 Mn |
| Mar 31, 2025 | 58.86 Mn |
| Mar 31, 2025 | 58.86 Mn |
| Dec 31, 2024 | 6.50 Mn |
| Dec 31, 2024 | 6.50 Mn |
| Sep 30, 2024 | 18.63 Mn |
| Sep 30, 2024 | 18.63 Mn |
| Jun 30, 2024 | 63.64 Mn |
| Jun 30, 2024 | 63.64 Mn |
| Mar 31, 2024 | 66.07 Mn |
| Mar 31, 2024 | 66.07 Mn |